Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines

Table 5

Odds ratio of all-cause and CV mortality by achievement of KDIGO clinical guideline, iPTH target.

	OR (95% CI)
	Model 1		Model 2		Model 3
iPTH (pg/mL), all-cause
<144	1.70 (1.25~2.33)	<0.001	2.00 (1.31~3.05)	0.001	1.95 (1.21~3.14)	0.006
144~648	1.00		1.00		1.00
>648	1.67 (1.03~2.70)	0.03	2.14 (1.21~3.77)	0.008	1.47 (0.77~2.81)	0.24
iPTH (pg/mL), CV
<144	1.12 (0.60~2.12)	0.72	1.20 (0.54~2.70)	0.65	1.68 (0.70~4.02)	0.24
144~648	1.00		1.00		1.00
>648	0.69 (0.21~2.31)	0.54	1.00 (0.28~3.54)	0.99	0.54 (0.13~2.21)	0.39

Logistic regression model:
Model 1: unadjusted.
Model 2: adjusted for age, sex, hemodialysis vintage, etiology of renal failure, EPO, vitamin-D analogs, antihypertensive agent, iron use, and parathyroidectomy.
Model 3: model 2 + baseline laboratory results (albumin, hemoglobin, cholesterol, triglyceride, glucose (fasting), ferritin, Ca, P, potassium, uric acid, urea, and cardiac-thoracic ratio).